BG-C477
- Generic Name
- BG-C477
A Study of BG-C477 in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- BeiGene
- Target Recruit Count
- 21
- Registration Number
- NCT06596473
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸Yale University, Yale Cancer Center, New Haven, Connecticut, United States
🇨🇳Sun Yat Sen University Cancer Center, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath